Featured Research

from universities, journals, and other organizations

Novel drug cocktail may improve clinical treatment for pancreatic cancer

Date:
April 27, 2014
Source:
Federation of American Societies for Experimental Biology (FASEB)
Summary:
A potential combination therapy for pancreatic cancer that, when used in mice, is more effective than the chemotherapy drug traditionally used alone has been developed by researchers. Pancreatic cancer is the fourth leading cause of cancer deaths in the U.S. and has the lowest overall survival rate of all major cancers (~6%).

Pancreatic cancer is the fourth leading cause of cancer deaths in the U.S. and has the lowest overall survival rate of all major cancers (~6%). With current treatment options being met with limited success it is anticipated that pancreatic cancer will move up to the second leading cause of cancer deaths by as early as 2015. Surgical removal of the tumor presents the best chance of survival, however only 15% of patients are eligible due to the late stage of diagnosis common with this disease. With very limited improvements in patient outcome over the last two decades there remains an enormous need for new therapies and treatment options.

David Durrant, a Ph.D. student in the laboratory of Dr. Rakesh Kukreja from the Pauley Heart Center at Virginia Commonwealth University's School of Medicine, is studying a novel combination therapy for the treatment of pancreatic cancer. The traditional chemotherapy drug, doxorubicin (DOX), has long been used in the treatment of several cancers. However, patients commonly acquire resistance to DOX because of increased activation of specific survival proteins or through increased expression of drug transporters which reduce cellular levels of the drug. This is especially true for pancreatic cancer, which does not respond to multiple treatment strategies, including those that contain DOX. The current research focuses on targeting these resistance mechanisms, which could possibly re-sensitize cancer cells to DOX, giving patients with pancreatic cancer another option in their fight against this devastating disease.

In the current study, Mr. Durrant used pancreatic cancer cells to assess the efficacy of combining DOX with a drug that inhibits the survival proteins involved in DOX resistance called BEZ235 (BEZ). The results showed that treatment with the combination of DOX and BEZ had significantly lower rate of surviving pancreatic cancer cells than the cells with single drug treatment. This correlated with the increase in DNA damage and apoptosis (programmed cell death). More interestingly, combining BEZ with DOX caused significantly higher accumulation of DOX in the cancer cells. These results demonstrate a dual function for BEZ i.e., its primary function of inhibiting survival proteins implicated in drug resistance and, a novel function of inhibiting drug export, thereby retaining DOX in the cancer cells. Furthermore, the in vitro effect of combining BEZ and DOX in enhanced killing of cancer cells was confirmed in the in vivo model. Treatment with BEZ and DOX in mice bearing pancreatic tumor xenografts resulted in inhibition of tumor growth as compared to BEZ and DOX alone.

These exciting results of combining BEZ with DOX in enhanced killing of pancreatic cancer cells may lead to clinical trials and potentially facilitate the development of a viable treatment option for patients with pancreatic cancer.

Mr. Durrant presented the findings during the Experimental Biology 2014 meeting on Sunday, April 27, 2014.

The study was funded by the American Heart Association and a National Institutes of Health MERIT Award.


Story Source:

The above story is based on materials provided by Federation of American Societies for Experimental Biology (FASEB). Note: Materials may be edited for content and length.


Cite This Page:

Federation of American Societies for Experimental Biology (FASEB). "Novel drug cocktail may improve clinical treatment for pancreatic cancer." ScienceDaily. ScienceDaily, 27 April 2014. <www.sciencedaily.com/releases/2014/04/140427185153.htm>.
Federation of American Societies for Experimental Biology (FASEB). (2014, April 27). Novel drug cocktail may improve clinical treatment for pancreatic cancer. ScienceDaily. Retrieved October 20, 2014 from www.sciencedaily.com/releases/2014/04/140427185153.htm
Federation of American Societies for Experimental Biology (FASEB). "Novel drug cocktail may improve clinical treatment for pancreatic cancer." ScienceDaily. www.sciencedaily.com/releases/2014/04/140427185153.htm (accessed October 20, 2014).

Share This



More Health & Medicine News

Monday, October 20, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

How Nigeria Beat Its Ebola Outbreak

How Nigeria Beat Its Ebola Outbreak

Newsy (Oct. 20, 2014) The World Health Organization has declared Nigeria free of Ebola. Health experts credit a bit of luck and the government's initial response. Video provided by Newsy
Powered by NewsLook.com
Another Study Suggests Viagra Is Good For The Heart

Another Study Suggests Viagra Is Good For The Heart

Newsy (Oct. 20, 2014) An ingredient in erectile-dysfunction medications such as Viagra could improve heart function. Perhaps not surprising, given Viagra's history. Video provided by Newsy
Powered by NewsLook.com
Ebola Worries End for Dozens on U.S. Watch Lists

Ebola Worries End for Dozens on U.S. Watch Lists

Reuters - US Online Video (Oct. 20, 2014) Forty-three people who had contact with Thomas Eric Duncan, the first person diagnosed with Ebola in the U.S., were cleared overnight of twice-daily monitoring after 21 days of showing no symptoms. Rough Cut (no reporter narration). Video provided by Reuters
Powered by NewsLook.com
CDC Calls for New Ebola Safety Guidelines

CDC Calls for New Ebola Safety Guidelines

AP (Oct. 20, 2014) Centers for Disease Control and Prevention Director Dr. Tom Frieden laid out new guidelines for health care workers when dealing with the deadly Ebola virus including new precautions when taking off personal protective equipment. (Oct. 20) Video provided by AP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins